![]() |
Resiquimod
- 英文名称:Resiquimod
- 品牌:WYTSCI
- 产地:进口
- 型号:1MG
- 货号:WT-AY-B10790
- cas:144875-48-9
- 价格: ¥1/mg
- 发布日期: 2025-04-10
- 更新日期: 2025-05-23
产品详请
产地 | 进口 |
品牌 | WYTSCI |
货号 | WT-AY-B10790 |
用途 | 科研检测 |
英文名称 | Resiquimod |
包装规格 | 1MG |
CAS编号 | 144875-48-9 |
别名 | Resiquimod |
纯度 | 98+% |
分子式 | |
是否进口 | 是 |
纯度:98% by TLC,;NMR (Conforms)
分子式:C17H22N4O2
分子量:314-38
溶剂:DMSO (30 mg/ml) Ethanol (15 mg/ml)
性状:White solid
存储:-20°C
Activity (short version):TLR7/8 agonist / Immune adjuvant
Function / Pharmacology:A Toll-like receptor 7/8 agonist.1 May be used as an immune adjuvant in cancer vaccines.2 Resiquimod-carrying synthetic vaccine particles augment the immune response to encapsulated antigen and exhibit strong local immune activation without inducing systemic cytokine release.3 Topical treatment of wild-type mice induces systemic autoimmune disease which may be used as a model of systemic Lupus erythematosus.4
分子式:C17H22N4O2
分子量:314-38
溶剂:DMSO (30 mg/ml) Ethanol (15 mg/ml)
性状:White solid
存储:-20°C
Activity (short version):TLR7/8 agonist / Immune adjuvant
Function / Pharmacology:A Toll-like receptor 7/8 agonist.1 May be used as an immune adjuvant in cancer vaccines.2 Resiquimod-carrying synthetic vaccine particles augment the immune response to encapsulated antigen and exhibit strong local immune activation without inducing systemic cytokine release.3 Topical treatment of wild-type mice induces systemic autoimmune disease which may be used as a model of systemic Lupus erythematosus.4